125 related articles for article (PubMed ID: 11239538)
1. Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro fertilization/intracytoplasmic sperm injection cycles.
Reljic M; Vlaisavljevic V; Gavric V; Kovacic B; Cizek-Sajko M
Fertil Steril; 2001 Mar; 75(3):539-43. PubMed ID: 11239538
[TBL] [Abstract][Full Text] [Related]
2. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
[TBL] [Abstract][Full Text] [Related]
3. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
[TBL] [Abstract][Full Text] [Related]
4. Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles.
Huang R; Fang C; Wang N; Li L; Yi Y; Liang X
Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():177-82. PubMed ID: 24862918
[TBL] [Abstract][Full Text] [Related]
5. Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology?
Royster GD; Krishnamoorthy K; Csokmay JM; Yauger BJ; Chason RJ; DeCherney AH; Wolff EF; Hill MJ
Fertil Steril; 2016 Aug; 106(2):363-370.e3. PubMed ID: 27172401
[TBL] [Abstract][Full Text] [Related]
6. Value of estradiol response after human chorionic gonadotropin administration in predicting in vitro fertilization success.
Meyer WR; Beyler SA; Baker ST; Somkuti SG; Lowden DA; Grainger DA
Fertil Steril; 1999 Sep; 72(3):542-5. PubMed ID: 10519632
[TBL] [Abstract][Full Text] [Related]
7. Should progesterone on the human chorionic gonadotropin day still be measured?
Martinez F; Rodriguez I; Devesa M; Buxaderas R; Gómez MJ; Coroleu B
Fertil Steril; 2016 Jan; 105(1):86-92. PubMed ID: 26453983
[TBL] [Abstract][Full Text] [Related]
8. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
[TBL] [Abstract][Full Text] [Related]
10. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
[TBL] [Abstract][Full Text] [Related]
11. Three protocols for monitoring follicle development in 587 unstimulated cycles of in vitro fertilization and intracytoplasmic sperm injection. A comparison.
Vlaisavljević V; Kovacic B; Reljic M; Lovrec VG
J Reprod Med; 2001 Oct; 46(10):892-8. PubMed ID: 11725733
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
Lin YJ; Lan KC; Huang FJ; Lin PY; Chiang HJ; Kung FT
Reprod Biol Endocrinol; 2015 May; 13():41. PubMed ID: 25967104
[TBL] [Abstract][Full Text] [Related]
13. Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles.
Ozçakir HT; Levi R; Tavmergen E; Göker EN
J Obstet Gynaecol Res; 2004 Apr; 30(2):100-4. PubMed ID: 15009611
[TBL] [Abstract][Full Text] [Related]
14. The comparison of microdose flare-up and multiple dose antagonist protocols based on hCG day estradiol (E2), progesterone (P) and P/E2 ratio among poor responder patients in ICSI-ET cycles.
Cicek MN; Kahyaoglu I; Kahyaoglu S
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):539-44. PubMed ID: 25753867
[TBL] [Abstract][Full Text] [Related]
15. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
16. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M
Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022
[TBL] [Abstract][Full Text] [Related]
17. The value of the progesterone-to-estradiol ratio on the day of hCG administration in predicting ongoing pregnancy and live birth rates in normoresponders undergoing GnRH antagonist cycles.
Cetinkaya ES; Berker B; Aytac R; Atabekoglu C; Sonmezer M; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):452-7. PubMed ID: 23932375
[TBL] [Abstract][Full Text] [Related]
18. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
[TBL] [Abstract][Full Text] [Related]
19. Decrease in preovulatory serum estradiol is a valuable marker for predicting premature ovulation in natural/unstimulated in vitro fertilization cycle.
Lu X; Khor S; Zhu Q; Sun L; Wang Y; Chen Q; Wu L; Fu Y; Tian H; Lyu Q; Cai R; Kuang Y
J Ovarian Res; 2018 Nov; 11(1):96. PubMed ID: 30463583
[TBL] [Abstract][Full Text] [Related]
20. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?
Azem F; Tal G; Lessing JB; Malcov M; Ben-Yosef D; Almog B; Amit A
Gynecol Endocrinol; 2008 Jul; 24(7):368-72. PubMed ID: 18645708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
